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Introduction
Applying positive airway pressure during ventilation is an
established means of augmenting ventilation and oxygena-
tion in patients with airflow obstruction. Expiratory positive
airway pressure (EPAP), as a means of counteracting
airway collapse, evolved from the observation that patients
with airflow limitation spontaneously expire through ‘pursed’
lips [1–3]. In patients, Barach and Swenson [1] demon-
strated bronchographically that bronchoconstriction was
reduced by 4–8 cmH2O positive airway pressure. Presum-
COPD = chronic obstructive pulmonary disease; CPAP = continuous positive airway pressure; EELV = end-expiratory lung volume; EPAP = expira-
tory positive airway pressure; IPAP = inspiratory positive airway pressure; Pabd = abdominal pressure; Paw = airway pressure; Pdi = transdi-
aphragmatic pressure; PEEP = positive end-expiratory pressure; Ppl = pleural pressure; Vt = tidal ventilation.
Abstract
Introduction Partial assist ventilation reduces work of breathing in patients with bronchospasm;
however, it is not clear which components of the ventilatory cycle contribute to this process.
Theoretically, expiratory positive airway pressure (EPAP), by reducing expiratory breaking, may be as
important as inspiratory positive airway pressure (IPAP) in reducing work of breathing during acute
bronchospasm.
Method We compared the effects of 10 cmH2O of IPAP, EPAP, and continuous positive airway
pressure (CPAP) on inspiratory work of breathing and end-expiratory lung volume (EELV) in a canine
model of methacholine-induced bronchospasm.
Results Methacholine infusion increased airway resistance and work of breathing. During
bronchospasm IPAP and CPAP reduced work of breathing primarily through reductions in
transdiaphragmatic pressure per tidal volume (from 69.4 ± 10.8 cmH2O/l to 45.6 ± 5.9 cmH2O/l and
to 36.9 ± 4.6 cmH2O/l, respectively; P < 0.05) and in diaphragmatic pressure–time product (from
306 ± 31 to 268 ± 25 and to 224 ± 23, respectively; P < 0.05). Pleural pressure indices of work of
breathing were not reduced by IPAP and CPAP. EPAP significantly increased all pleural and
transdiaphragmatic work of breathing indices. CPAP and EPAP similarly increased EELV above control
by 93 ± 16 ml and 69 ± 12 ml, respectively. The increase in EELV by IPAP of 48 ± 8 ml (P < 0.01) was
significantly less than that by CPAP and EPAP.
Conclusion The reduction in work of breathing during bronchospasm is primarily induced by the IPAP
component, and that for the same reduction in work of breathing by CPAP, EELV increases more.
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ably, the increased airway pressure reflects backward,
thereby increasing intraluminal bronchial pressure and pre-
venting dynamic airway collapse during exhalation.
Brochard and coworkers [4] documented that noninvasive
application of positive airway pressure could support indi-
viduals with chronic airflow obstruction without the need for
intubation of the trachea and mechanical ventilation. Pre-
sumably, work of breathing is reduced by positive airway
pressure.
In support of this concept, studies using either continuous
positive airway pressure (CPAP) or positive end-expiratory
pressure (PEEP) during airflow limitation have shown a
reduction in the inspiratory work of breathing [5–8]. These
studies have further suggested that the use of CPAP or
PEEP may benefit mechanically ventilated patients with
chronic obstructive pulmonary disease (COPD) by facilitating
weaning from positive pressure ventilation [6,7]. Furthermore,
CPAP delivered by mask may also be useful in avoiding the
need for intubation and mechanical ventilation in patients with
COPD with acute hypercapnic respiratory failure [7]. Finally,
CPAP may also be useful in improving exercise tolerance in
patients with COPD [9,10].
CPAP may potentially be useful in the management of acute
bronchial asthma, which increases inspiratory work of breath-
ing and predisposes patients to air trapping, dynamic hyper-
inflation, and auto-PEEP. Martin and coworkers [5] showed
that CPAP applied by mask to patients with histamine-
induced bronchospasm reduced pulmonary resistance and
inspiratory work of breathing. Shivaram and colleagues [11]
applied graded levels of CPAP by mask to patients with
acute asthma and observed an improved sensation of
comfort, reduced inspiratory work of breathing, and increased
flow in the late phase of tidal expiration. In a prospective,
single-blind study [12], patients with acute bronchial asthma
who received 5 and 7.5 cmH2O CPAP by nasal mask
showed a significant improvement in dyspnea and a reduc-
tion in respiratory rate without any deleterious effects on
hemodynamics, gas exchange, or expiratory airflow.
Conceptually, CPAP can be partitioned into two compo-
nents: inspiratory positive airway pressure (IPAP) and EPAP.
IPAP may decrease the work of breathing by supplementing
inspiratory airway pressure and decreasing inspiratory muscle
work. EPAP may counteract the inspiratory threshold
imposed by auto-PEEP and increase intraluminal pressure,
which ‘pneumatically’ holds the airway open, thus preventing
dynamic airway collapse. Furthermore, EPAP may recruit
expiratory muscles, which can defend end-expiratory lung
volume (EELV) and aid in unloading inspiratory muscles,
further decreasing the inspiratory effort [5,13]. Separating the
effects of EPAP from those of IPAP is relevant clinically
because of the common use of bilevel positive airway pres-
sure in the management of patients with airflow obstruction.
However, neither the relative contribution of either EPAP or
IPAP, nor the mechanisms by which they exert their effect on
work of breathing are currently understood.
Thus, we compared the independent effects of IPAP, EPAP,
and CPAP on the inspiratory work of breathing and EELV
changes using a canine model of methacholine-induced
bronchospasm. Our data suggest that both with and without
hyperinflation the IPAP component of CPAP is responsible
for the reduction in the work of breathing during acute
bronchoconstriction. Furthermore, the blunted increases in
EELV occurring after positive expiratory pressure (EPAP and
CPAP) during bronchoconstriction appear to result from
expiratory muscle recruitment.
Method
Eighteen fasting mongrel dogs (19.6 ± 0.5 kg) were anes-
thetized with pentobarbital (30 mg/kg), intubated (9.0 mm
ID), and ventilated (10–15 ml/kg, fractional inspired oxygen
0.4–0.5, frequency adjusted to maintain the end-tidal partial
carbon dioxide tension in the range 35–40 mmHg). Anesthe-
sia was maintained with pentobarbital (1 mg/kg per hour).
Temperature was kept between 36–38°C by external heat.
Airway pressure (Paw) was measured 5 cm from the distal
end of the endotracheal tube. Heart rate was derived from
the electrocardiogram, arterial pressure from a peripheral
arterial catheter, and pulmonary arterial pressure and pul-
monary arterial occlusion pressure from a balloon-tip pul-
monary arterial catheter. Infusion of 0.9 N NaCl was done to
keep the end-expiratory pulmonary arterial occlusion pres-
sure between 7 and 10 mmHg. A 5 cm air-filled balloon
catheter placed in the mid-chest via 5 cm laporotomy was
used to measure pleural pressure (Ppl). Accuracy of Ppl was
validated as previously described [14]. Another balloon
catheter was placed below the left hemidiaphragm to
measure abdominal pressure (Pabd). Respiratory inductive
plethysmography bands (Respitrace 900SC, NIMS, North
Bay Village, FL, USA) were placed around the rib cage and
abdomen (Fig. 1). The animals were then placed prone and
allowed to stabilize for 30 min.
Proximal endotracheal tube flow was measured using a
pneumotachograph. The dynamic characteristics of the lungs,
chest wall, and total respiratory system during tidal breathing
were calculated as the ratio of tidal changes in trans-
pulmonary pressure, Ppl, and Paw to tidal volume (Vt),
respectively. Pressure–time products of Ppl and transdi-
aphragmatic pressure (Pdi) were calculated as the area of the
inspiratory portion of the pressure curve (Fig. 2). The dura-
tions of one breath, inspiration, and expiration were measured
from the airflow tracing. Pulmonary resistance was measured
using the multiple airflow interrupter method [15] after airway
secretions were removed by suction and three double Vts
were administered.
The respiratory inductive plethysmographically derived Vt was
calibrated using the isovolume maneuver and validatedR74
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against the pneumotachograph-derived volume [16] and a
super syringe. The absolute lung volume change measured in
duplicate with initiation and removal of positive airway pres-
sure was used to estimate changes in EELV (DC-coupled
mode; Fig. 3). Auto-PEEP was measured using the inspiratory
flow-initiation method [17].
IPAP and CPAP were created using the BiPAPTM (Respironics,
Monroeville, PA, USA). IPAP has a mandatory minimum EPAP
level of 2 cmH2O. EPAP was generated using a non-rebreath-
ing T-piece valve with a threshold spring-loaded PEEP valve
attached to the expiratory limb.
All animals received no positive airway support, and
10 cmH2O IPAP, EPAP, and CPAP before and during metha-
choline-induced bronchospasm. The order of IPAP, EPAP,
and CPAP was varied using a Latin Square design. Measure-
ments were taken after 5 min spontaneous breathing, with or
without positive airway pressure breathing. Bronchospasm
was induced by methacholine infusion (0.1 to 0.3 mg/kg per
min) until tearing, hypersalivation, and diarrhea were noted.
Afterward, 20–30 min elapsed to achieve maximal bron-
choconstriction [18]. The animals were then given pentobar-
bital boluses and killed by bolus KCl infusion. Placement of
catheters was confirmed at necropsy.
Three to six breaths were analyzed per step. All off positive
airway pressure data were pooled. Analysis of variance for
repeated measures with a Newman–Keuls correction was
applied if a statistical difference was detected (CRUNCH,
Oakland, CA, USA).
Results
Effects of methacholine-induced bronchospasm on
control variables
Pooled control respiratory variables before and after induc-
tion of methacholine-induced bronchospasm are summarized
in Table 1. Methacholine infusion resulted in an increase in
respiratory frequency (P < 0.002) along with a less significant
drop in Vt (P < 0.03), which resulted in an overall increase in
minute ventilation (P < 0.05). Peak and mean airflow rates
were unchanged during both inspiratory and expiratory
phases of respiration after the administration of methacholine.
Resistance increased and the dynamic compliance of the
lung, chest wall, and entire respiratory system decreased
significantly (Table 1, Fig. 4). Respiratory system mechanics
remained constant throughout the entire experimental time
period. The inspiratory effort increased significantly during
methacholine infusion, as estimated by changes in tidal Ppl,
Pdi, and their respective pressure–time products. No measur-
able auto-PEEP was detected using the inspiratory flow initia-
tion method in any animal. In further support of this lack of
hyperinflation, end-expiratory transpulmonary pressure, which
is used to estimate absolute end-expiratory lung volume,
exhibited no change during methacholine infusion (Fig. 5).
End-expiratory Pabd, which is used to estimate abdominal
expiratory muscle activity, approximately doubled (P < 0.01)
during methacholine infusion (Fig. 5). However, end-expira-
Figure 1
Animal model instrumentation. AB, abdomen signal; BiPAPTM,
apparatus delivering inspiratory positive airway pressure and
continuous positive airway pressure (Respironics, Monroeville, PA,
USA); Pabd, abdominal pressure; Part, arterial pressure; Paw, airway
pressure; Ppl, pleural pressure; RC, rib cage signal; SUM, summed
signal from rib cage and abdomen.
Figure 2
Representative strip-chart recorder tracing describing the methods
used for measuring tidal swings in the pleural pressure (Ppl) and
transdiaphragmatic pressure (Pdi) tracings. The pressure–time
integrals of the diaphragm (∫Ppldt) and pleural pressure (∫Pdidt) were
computer-calculated as the area of the pressure tracing defined by the
inspiratory portion of the airflow tracing. EXP, expiratory; INSP,
inspiratory.R75
tory Ppl did not increase during methacholine infusion. The
static compliance of the respiratory system was unchanged
during methacholine infusion, as measured in three paralyzed
animals with stepwise inflation and deflation maneuvers.
Effects of inspiratory, expiratory, and continuous
positive airway pressure
Stability of animal preparation
The animals remained stable throughout the experimental
time period, as indicated by no detectable changes in all
measured variables, either before or after methacholine infu-
sion, during control periods off positive pressure support.
The constancy of the control data also supports the
assumption that the effects of 5 min IPAP, EPAP, and
CPAP did not persist after the discontinuation of positive
airway pressure.
Breathing pattern
During methacholine infusion, applications of all forms of pos-
itive airway pressure were associated with similar increases in
Vt (P < 0.0002) and a corresponding decrease in respiratory
rate (P < 0.01) with a constant minute ventilation. Peak inspi-
ratory flow rate increased with IPAP (P < 0.05) and EPAP
(P < 0.05), whereas the ratio of the duration of inspiration to
that of one full breath was unchanged. During exhalation,
peak expiratory flow, mean expiratory flow, and the ratio of the
duration of expiration to that of one full breath were unaltered
by any form of positive airway pressure (Table 1).
Inspiratory work of breathing
As summarized in Fig. 6, IPAP and CPAP reduced the work
of breathing primarily through changes in diaphragmatic work,
as estimated by changes in Pdi tidal swings (P < 0.05) and
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Figure 3
On the left is a tracing of the summed signal from respiratory inductive plethysmography used for calculating changes in end-expiratory lung volume
(EELV). The arrow labeled ‘ON’ depicts the switch from spontaneous breathing to the initiation of 10 cmH2O of inspiratory positive airway pressure
(IPAP), expiratory positive airway pressure (EPAP), or continuous positive airway pressure (CPAP). The arrow labeled ‘OFF’ depicts the removal of
positive airway pressure and return to spontaneous breathing. Changes in EELV were quantified by measuring changes in the baseline portion of
the tracing. The changes in EELV induced by the addition (ON) and removal (OFF) of positive airway pressure were averaged, and the values are
reported in Fig. 7. The increase in height of the summed signal represents changes in tidal volume (Vt), as measured using plethysmography, but
these values were not measured for these experiments. On the right is a graph comparing plethysmographically derived summed signal
measurements of changes in EELV with spirometer-derived values in three pharmacologically paralyzed animals during both inflation and deflation
of the lungs.
Figure 4
Lung mechanics before and after intravenous methacholine infusion.
Resistance of the respiratory system (Rrs) was significantly increased
and dynamic compliance (Cdyn) was significantly decreased, as
measured in all animals (n = 18). The static compliance (Cst) was
unchanged after methacholine administration, as measured in three
pharmacologically paralyzed animals. *P < 0.05.
Before During
Methacholine
Before During
Methacholine
Before During
Methacholine
Rrs
(cm H2O/L/sec)
Cdyn
(ml/cm H2O)
Cst
(ml/cm H2O)
14
12
10
8
6
4
2
0
200
150
100
50 10
15
20
25
*
*R76
the diaphragmatic pressure–time product (P < 0.05). Although
CPAP tended to reduce further the work of breathing over
IPAP alone, this additional reduction was not statistically differ-
ent. The use of EPAP alone increased the Ppl and Pdi work of
breathing values. IPAP and CPAP similarly reduced Ppl work,
but this difference did not achieve statistical significance.
End-expiratory lung volume changes
As summarized in Fig. 7, IPAP, EPAP, and CPAP all
increased EELV but to different degrees. Before metha-
choline administration CPAP resulted in the greatest increase
in EELV, followed by both EPAP and IPAP (P < 0.01). During
methacholine infusion, CPAP and EPAP increased EELV
similarly but to a greater extent than did IPAP (P < 0.01).
IPAP was associated with a small but similar increase in
EELV before and during methacholine infusion. However, the
increases in EELV after EPAP and CPAP were consistently
greater before methacholine infusion (P < 0.005).
Expiratory muscle activity
Following the initial increase in end-expiratory Pabd during
methacholine infusion, there was no significant change with
IPAP, EPAP, and CPAP. However, end-expiratory Ppl did
increase significantly following IPAP (P < 0.05), EPAP
Critical Care    April 2004 Vol 8 No 2 Miro et al.
Table 1
Respiratory variables during methacholine and positive airway pressures
Methacholine (control) Methacholine (study)
Before During IPAP EPAP CPAP
Vt (ml) 87 ± 17 139 ± 9* 194 ± 9‡ 175 ± 13‡ 200 ± 13‡
Respiratory rate (breaths/min) 40 ± 5 71 ± 8† 56 ± 6‡ 47 ± 6‡ 59 ± 9‡
Ve (l/min) 7.2 ± 0.9 10.1 ± 1.0* 11.4 ± 1.1 9.3 ± 1.4 11.2 ± 1.6
Vinsp,peak (l/min) 22 ± 2 24 ± 3 32 ± 3‡ 32 ± 4‡ 28 ± 3
Vt/Ti (ml/s) 306 ± 29 368 ± 36 449 ± 40 446 ± 56 423 ± 54
Ti/Ttot 0.39 ± 0.02 0.46 ± 0.01* 0.41 ± 0.02 0.38 ± 0.04 0.43 ± 0.02
Vexp,peak (l/min) 33 ± 2 27 ± 3 29 ± 3 28 ± 3 32 ± 3
Vt/Te (ml/s) 313 ± 21 331 ± 30 359 ± 25 345 ± 33 368 ± 52
Te/Ttot 0.42 ± 0.04 0.52 ± 0.01 0.53 ± 0.02 0.49 ± 0.05 0.52 ± 0.03
C dyn,lung (ml/cmH2O) 70 ± 7 40 ± 4* 28 ± 3‡ 20 ± 2‡ 43 ± 4
C dyn,cw (ml/cmH2O) 124 ± 21 49 ± 7† 61 ± 9 36 ± 6 79 ± 17
C dyn,rs (ml/cmH2O) 232 ± 50 92 ± 10* 91 ± 8 60 ± 8‡ 105 ± 8
Ptp,exp (cmH2O) –0.4 ± 0.6 –0.8 ± 0.5 1.4 ± 0.9 5.0 ± 1.3‡ 5.6 ± 1.1‡
Pabd,exp (cm H2O) 4.5 ± 0.9 9.1 ± 1.8* 10.0 ± 1.9 11.3 ± 1.5 11.0 ± 2.0
Ppl,exp (cmH2O) –0.6 ± 0.1 2.2 ± 0.2 4.0 ± 0.2‡ 4.9 ± 0.2‡ 4.6 ± 0.3‡
C dyn,cw; dynamic compliance of the chest wall; C dyn,lung, dynamic compliance of the lung; C dyn,rs, dynamic compliance of the respiratory
system; Pabd,exp, end-expiratory abdominal pressure; Ppl,exp, end-expiratory pleural pressure; Ptp,exp, end-expiratory transpulmonary pressure;
Te, expiratory time; Ti, inspiratory time; Ttot, duration of one breath; Ve, minute ventilation; Vexp,peak, peak expiratory volume; Vinsp,peak, peak
inspiratory volume; Vt, tidal volume. *P < 0.05, versus pre-methacholine values; †P < 0.005, versus pre-methacholine values; ‡P < 0.05, versus
post-methacholine control values.
Figure 5
Effects of intravenous methacholine infusion on auto-positive end-
expiratory pressure (auto-PEEP), end-expiratory transpulmonary
pressure (Ptp,exp), and end-expiratory abdominal pressure (Pabd,exp).
Methacholine induced no significant hyperinflation according to the
auto-PEEP and Ptp,exp measurements. However, expiratory muscle
activity significantly increased after methacholine administration, as
demonstrated by the increase in Pabd,exp. *P < 0.01.
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(P < 0.01), and CPAP (P < 0.01), suggesting that the expira-
tory muscles of the rib cage were activated during these ven-
tilatory changes (Table 1).
Lung mechanics
The dynamic characteristics of the total respiratory system
(lungs plus chest wall) were unaffected by IPAP and CPAP
but were reduced with the use of EPAP (P < 0.05), whereas
measures of dynamic chest wall mechanics were unaltered
by any form of positive airway pressure (Table 1).
Isovolume expiratory airflow
In three animals the corrected expiratory isovolume–flow
curves were analyzed after IPAP, EPAP, and CPAP. In all cases
the positions of all positive airway pressure curves were shifted
to the left (increased EELV) but the shape of the flow decays
were similar, indicating simply a parallel shift in the flow–volume
relation without change in expiratory airway resistance (Fig. 8).
Discussion
Positive airway pressure is often used to support sponta-
neously breathing patients with increased airways resistance.
Our data demonstrate, in an animal model of methacholine-
induced bronchospasm, that the inspiratory work of breathing
was reduced with 10 cmH2O IPAP and CPAP, whereas this
work was significantly increased with 10 cmH2O EPAP.
These data suggest that during bronchoconstriction, with or
without hyperinflation, the presence of inspiratory pressure
support primarily reduces the inspiratory work of breathing.
As the respiratory workload is increased, whether by changes
in resistance or in compliance, inspiratory muscle work
increases to meet the demands of generating a greater
transpulmonary inflating pressure to effect a similar volume
change. During airflow limitation, the inspiratory work of
breathing may be increased by a variety of mechanisms,
including increased airway resistance, an inefficient
diaphragm length–tension relation from hyperinflation, or an
inspiratory threshold load imposed by auto-PEEP. Inspiratory
positive airway pressure support, such as that delivered by
either IPAP or CPAP, can partially or completely satisfy these
increased inspiratory muscle demands during spontaneous
breathing [5–7,19].
Assuming that Ppl measurements represent the rib cage
musculature and that Pdi represents diaphragmatic pressure
work [20], we noted quantitatively different responses in the
distribution of work after IPAP and CPAP. Although both Ppl
and Pdi indices of inspiratory work decreased after IPAP and
CPAP, only the reduction in Pdi work achieved statistical sig-
nificance. This was true for both absolute tidal pressure
swings and the pressure–time products for both Ppl and Pdi.
Other studies have similarly shown a significant reduction in
tidal Pdi swings but not esophageal pressure swings with
CPAP in patients with airflow limitation [6,10]. A possible
explanation may be a redistribution of respiratory work away
from the diaphragm, with the rib cage musculature receiving a
greater proportion of the workload. This hypothesis is sup-
ported by studies showing that increasing levels of pressure
support to patients who are chronically mechanically venti-
lated resulted in a decrease work of breathing and increased
Vt [21]. Alternatively, CPAP has been shown to hyperinflate
preferentially the rib cage compartment over the abdominal
compartment in patients with COPD and acute histamine-
induced bronchospasm [5,22], which may limit the CPAP-
induced reduction in Ppl workload. Because we did not
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Figure 6
Changes in pleural (left) and transdiaphragmatic (right) work indices
after the application of 10 cmH2O inspiratory positive airway pressure
(IPAP), expiratory positive airway pressure (EPAP), and continuous
positive airway pressure (CPAP). IPAP and CPAP significantly
reduced transdiaphragmatic pressure (P < 0.05) but not pleural
pressure work indices compared with control conditions. EPAP
significantly increased all indices of respiratory work (*P < 0.05).
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Figure 7
Change in end-expiratory lung volume (EELV) after 10 cmH2O
inspiratory positive airway pressure (IPAP), expiratory positive airway
pressure (EPAP), and continuous positive airway pressure (CPAP)
before and after methacholine infusion. For the same positive airway
pressure condition, ∆EELV was significantly less (*P < 0.05) after
methacholine.
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individually examine the rib cage and abdominal plethysmo-
graphic EELV component changes, we cannot determine
whether this observation was also true in our model.
EPAP-induced hyperinflation increased all indices of respira-
tory work. This could not be explained by an increase in EELV
alone because a similar amount of hyperinflation occurred with
CPAP but CPAP reduced respiratory work. Although this form
of expiratory Paw most resembles the spontaneous ‘pursed
lip’ breathing noted in patients with obstructive airway dis-
eases [1–3], it does not appear to reduce the inspiratory work
of breathing. Other investigators have demonstrated that
EPAP alone increases the work of breathing, whereas CPAP
reduces this work in an unselected patient population with
various etiologies of respiratory failure [23]. O’Donnell and
coworkers [9] also found that 4–5 cmH2O EPAP significantly
increased the subjective level of dyspnea during submaximal
exercise in patients without COPD but it had an inconsistent
response in those with COPD. Thus, hyperinflation with EPAP,
if inspiration is not simultaneously pressure supported, does
not appear to reduce inspiratory work.
For equal reductions in inspiratory work with IPAP and CPAP,
CPAP resulted in a greater increase in EELV (93 ± 69 ml
versus 48 ± 31 ml). This hyperinflation potentially is mechani-
cally disadvantageous to the diaphragm. This paradox
between decreases in inspiratory work despite increases in
EELV with CPAP has been seen in other studies using CPAP
in patients with obstructive airway disease [6,7]. Petrof and
coworkers [6] applied increasing levels of CPAP (5, 10, and
15 cmH2O) to mechanically ventilated patients and showed a
progressive reduction in work of breathing despite a simulta-
neous increase in EELV. This was explained by regional in-
homogeneities of the mechanical properties of the diseased
lungs [6]. Lung units with the longest time constants or
highest auto-PEEP levels require higher levels of CPAP to
produce reductions in the inflation work in these diseased
areas, whereas lung regions with shorter time constants or
less auto-PEEP become overinflated at higher CPAP levels.
Although the net effect is a reduction in respiratory workload,
CPAP-induced hyperinflation may lead to adverse effects
including impairment in gas exchange, barotrauma, and
hemodynamic deterioration.
This CPAP-induced paradoxic decrease in inspiratory work of
breathing and increase in lung volume has made it difficult to
define the ‘optimal’ CPAP levels for ventilatory support in
airflow limitation. When auto-PEEP is present, the amount of
CPAP or PEEP needed on exhalation to counteract the
elastic recoil of the respiratory system has been suggested to
be somewhere at or near the measured auto-PEEP level [7].
However, this approach is oversimplified and invalid for a
number of reasons. First, as Petrof and coworkers [6]
showed, the work of breathing continued to decline even
when CPAP levels exceeded the measured auto-PEEP levels
in patients with less than predicted increases in EELV.
However, Gay and coworkers [24] demonstrated that apply-
ing external PEEP to airflow-limited patients, even at airway
pressure levels substantially below auto-PEEP, can reduce
isovolume expiratory flow rates and significantly increase
EELV. Finally, the methodology used to measure auto-PEEP
can influence the values obtained in the same individual.
Because all regions of the lungs are not affected to the same
degree, certain lung units may have longer time constants
and therefore be more predisposed to hyperinflation than
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Figure 8
Airflow–volume tidal expiratory curves shifted to allow airflow
comparisons under isovolumic conditions in three randomly selected
animals. Inspiratory positive airway pressure (IPAP) and continuous
positive airway pressure (CPAP) produced a leftward parallel shift in
the expiratory curves, which is indicative of increases in end-expiratory
lung volume (EELV) without changes in expiratory resistance
compared with control conditions. Functional residual capacity (FRC)
was defined as the EELV during spontaneous breathing (no positive
airway pressure). Relative volume represents the increases in EELV
above FRC, as defined above.R79
other areas. The end-expiratory technique first described by
Pepe and Marini [25] accounts for all lung units in communi-
cation with the airway opening where pressure is being mea-
sured, and it therefore represents the ‘average’ auto-PEEP
value of an inhomogeneous respiratory system. The inspira-
tory flow-initiation method used in this study and initially
described by Rossi and coworkers [17] measures only the
‘least’ auto-PEEP, because the inspiratory flow begins as
soon the lowest auto-PEEP threshold is exceeded. In one
study in which the two techniques were compared in the
same individuals [6], the end-expiratory occlusion auto-PEEP
values were always higher than those obtained with the inspi-
ratory flow technique. Thus, at any given level of positive expi-
ratory pressure with CPAP, EPAP, or PEEP, it is likely that
regional lung unit volume can increase, decrease, or remain
unchanged depending on regional mechanical properties and
regional auto-PEEP levels. Lung volume could theoretically be
decreased if the backpressure provided by CPAP or EPAP
pneumatically splinted open flow-limiting airway segments,
thereby reducing expiratory airway resistance and increasing
expiratory airflow. Alternatively, through expiratory muscle
recruitment, CPAP or EPAP may also protect or even
decrease EELV [13,26].
Ranieri and coworkers [27] studied the effects of progressive
levels of PEEP from 5 to 15 cmH2O in pharmacologically
paralyzed, mechanically ventilated patients with severe
obstructive airway disease and found that hyperinflation did
not occur until the external PEEP exceeded 85% of the auto-
PEEP levels present. However, because the degree of hyper-
inflation depends on several factors such as available
duration of expiration, respiratory frequency, and lung
mechanics, this simple guideline cannot necessarily be
extrapolated to nonparalyzed, spontaneously breathing
patients, in whom breathing patterns may vary considerably.
We noted that, for similar levels of IPAP, EPAP, and CPAP,
EELV increased to a much lesser degree during metha-
choline infusion. Several possible explanations may exist.
First, if auto-PEEP is present, then EPAP or CPAP should not
significantly increase EELV until the auto-PEEP level is
exceeded [5,7,28]. However, this cannot be generalized to a
multicompartment, inhomogeneous system because alveolar
driving pressure varies and can be regionally reduced at expi-
ratory airway pressures below the auto-PEEP levels as
described above [24,29]. In the present study, despite signifi-
cant methacholine-induced bronchoconstriction and rapid
respiratory frequencies, we observed no measurable auto-
PEEP using the inspiratory flow-initiation technique. The
capacity of this technique to detect auto-PEEP, if present in
our model, was subsequently validated in two animals in
which the progressive addition of external PEEP was associated
with respiratory inductive plethysmographic increases in EELV,
as described by Hoffman and coworkers [28]. Thus, our
model exhibited no significant dynamic hyperinflation. Hyper-
inflation cannot explain the blunted increases in EELV during
methacholine infusion. Another possible explanation is that
methacholine might have significantly decreased the static
compliance properties of the respiratory system, such that for
the same pressure there would be a correspondingly smaller
volume change. However, in three paralyzed animals, progres-
sive inflation and deflation curves revealed no methacholine-
induced change in static lung or chest wall compliance.
Finally, the explanation we favor is the influence of significant
increases in expiratory muscle activity during methacholine-
induced bronchospasm, as noted by changes in end-expiratory
Pabd and Ppl. Expiratory muscle activity was increased with
methacholine infusion and remained elevated during the
entire methacholine stage of the experiment. This persistent
tonicity of the expiratory muscles would decrease the compli-
ance of the chest and abdominal wall, and reduce the EELV
changes of EPAP and CPAP. There was no significant rela-
tion between Pabd and increases in lung volume (r = 0.34,
P = 0.07). However, the change in end-expiratory Ppl and
EELV had a curvilinear relation, indicating that EELV changes
were dependent on the degree of expiratory rib cage activity.
The more positive end-expiratory Ppl values had the lowest
increase in EELV after EPAP and CPAP (r = 0.42, P < 0.05).
This expiratory muscle activity would be obliterated with
neuromuscular paralysis, which is consistent with our obser-
vations. Interestingly, Lessard and coworkers [30] noted that
increasing IPAP increased both auto-PEEP and expiratory
efforts in individuals with chronic airflow obstruction receiving
pressure support ventilation. Although EELV was not
increased, stop flow measured airway pressure increased,
presumably due to increased expiratory muscle activity.
Mancebo and coworkers [31] documented that when extrinsic
PEEP was increased up to the auto-PEEP value, respiratory
drive, estimated by the pressure at the mouth 0.1 s into an
obstructed spontaneous breath (P0.1), also decreased, with
P0.1 and work of breathing decreasing in parallel. These data
collectively suggest that mechanical factors other than
increasing EELV induce increased respiratory effort, but that
respiratory drive matches ventilator manipulated changes in
work of breathing.
As others have suggested, and as our data demonstrate, the
application of positive airway pressure during exhalation, as
with CPAP and EPAP, may recruit expiratory muscles of res-
piration [5,6,13,26]. Although this will increase the work per-
formed by the expiratory muscles, the effort of the inspiratory
muscle can be reduced through a variety of mechanisms,
including cephalad displacement of the diaphragm to a more
efficient length–tension position, passive outward recoil of
the rib cage after relaxation of the expiratory muscles, and
diaphragmatic descent by reduction in intra-abdominal pres-
sure after muscular relaxation [6,13,32,33].
However, the recruitment patterns of expiratory muscles are
incompletely understood during conditions of increased res-
piratory workload or in response to expiratory airway pressure
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as with EPAP, PEEP, or CPAP. We noted a difference in the
expiratory activity of the rib cage and abdominal components
after application of various forms of Paw. After IPAP, EPAP,
and CPAP no changes occurred in end-expiratory Pabd com-
pared with unsupported breathing, indicating that no form of
positive Paw recruited abdominal expiratory muscles.
However, all forms of Paw increased end-expiratory Ppl,
which is consistent with activation of the expiratory rib cage
musculature. Thus, our data suggesting that IPAP and CPAP
preferentially unload the diaphragm over the rib cage muscu-
lature during spontaneous inspiration may be attributed to the
redistribution of workload and selective recruitment of the
expiratory rib cage muscles to assist with respiratory work.
Further work using electromyography would be useful in con-
firming our interpretations of the muscular recruitment and
derecruitment patterns after the application of positive Paw
during acute bronchospasm.
In our attempt to elucidate whether the decreased inspiratory
work of breathing by IPAP and CPAP were due only to inspi-
ratory pressure assistance, we examined the isovolume flow
curves in three animals after methacholine infusion. We found
that the position of the expiratory flow decay was shifted to
the left, which is consistent with increases in EELV, but the
shape of the expiratory flow–volume segment was similar
during IPAP and CPAP. This flow–volume behavior indicates
that, although our animals had a significant degree of
bronchospasm, airflow limitation was absent. Furthermore,
although previous studies have postulated that CPAP may
also reduce airway resistance through stimulation of tracheal
stretch receptors [5], this was not apparent by analysis of the
isovolume flow curves. Thus, it does not appear that the
CPAP reduction in the inspiratory work of breathing was due
to changes in expiratory flow resistance.
Conclusion
Our data are consistent with an inspiratory effect of positive
airway pressure during acute bronchospasm as a factor mini-
mizing the increased work of breathing. The diaphragm appears
to be preferentially unloaded during inspiration compared with
the thoracic cage inspiratory musculature. Furthermore, general-
ized increases in expiratory muscle tone, predominantly in the rib
cage compartment, appear to reduce the positive expiratory
airway pressure-induced increases in EELV.
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